View Rule

Printer-Friendly Version Download RIN Data in XML

SSA

RIN: 0960-AD78

Publication ID: Fall 2010

Title: Revised Medical Criteria for Evaluating Endocrine System Disorders (436P)
Abstract: Sections 9.00 and 109.00, Endocrine System, of appendix 1 to subpart P of part 404 of our regulations describe endocrine system disorders that are considered severe enough to prevent an individual from doing any gainful activity, or that cause marked and severe functional limitations for a child claiming SSI payments under title XVI. We will revise these sections to ensure that the medical evaluation criteria are up-to-date and consistent with the latest advances in medical knowledge and treatment.
Agency: Social Security Administration(SSA)	Priority: Other Significant
RIN Status: Previously published in the Unified Agenda	Agenda Stage of Rulemaking: Final Rule Stage
Major: No	Unfunded Mandates: No
CFR Citation: 20 CFR 404.1500, app 1
Legal Authority: 42 USC 402 42 USC 405(a) 42 USC 405(b) 42 USC 405(d) to 405(h) 42 USC 416(i) 42 USC 421(a) 42 USC 421(i) 42 USC 423 42 USC 902(a)(5) 42 USC 1381a 42 USC 1382c 42 USC 1383 42 USC 1383b

Legal Deadline: None

Statement of Need: We are revising the listings for endocrine disorders because, since we last published final rules making comprehensive revisions to the endocrine listings in 1985, medical science has made significant advances in detecting endocrine disorders at earlier stages, and new treatments have resulted in better management of these conditions. Consequently, most endocrine disorders do not reach listing-level severity because they do not become sufficiently severe or do not remain at a sufficient level of severity long enough to meet our 12-month duration requirement. For persons whose endocrine disorders are not controlled, we make individualized determinations about disability. We have determined that, with the exception of children under age 6 who have diabetes mellitus (DM) and require daily insulin, we should no longer have listings in section 9.00 and 109.00 based on endocrine disorders alone.

Summary of the Legal Basis: Administrative--not required by statute or court order.

Alternatives: We considered not revising the listings or making only minor technical changes and continuing to use our current criteria. However, we believe that finalizing these revisions is preferable because of the medical advances that have been made in treating and evaluating these types of disorders.

Anticipated Costs and Benefits: Not yet determined.

Risks: None.

Timetable:

Action	Date	FR Cite
ANPRM	08/11/2005	70 FR 46792
ANPRM Comment Period End	10/11/2005
NPRM	12/14/2009	74 FR 66069
NPRM Comment Period End	02/12/2010
Final Action	01/00/2011

Regulatory Flexibility Analysis Required: No	Government Levels Affected: None
Small Entities Affected: No	Federalism: No
Included in the Regulatory Plan: Yes
Public Comment URL: www.regulations.gov
RIN Data Printed in the FR: No
Agency Contact: Cheryl A. Williams Director Social Security Administration Office of Medical Policy, 6401 Security Boulevard, Baltimore, MD 21235-6401 Phone:410 965-1020 Email: cheryl.a.williams@ssa.gov Brian J. Rudick Social Insurance Specialist, Regulations Writer Social Security Administration Office of Regulations and Reports Clearance, 6401 Security Boulevard, Baltimore, MD 21235-6401 Phone:410 965-7102 Email: brian.rudick@ssa.gov